Register now for Webinar 2 of the Targets for Cancer IO: A Deep Dive series. Gain practical insights into emerging immunotherapy strategies for MSS Colon Cancer and the science driving future advances. https://www.sitcancer.org/edu/webinars/targets-for-cancer-io

Emerging targets are shaping the future of immuno-oncology. Join Alessandra Curioni-Fontecedro, MD, for B7-H3 (CD276) in Cancer at the 2026 SITC EU Immuno-Oncology Drug Development Summit. Register today: https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

We’re excited to announce the NCI Immunotherapy Fellowship! This one-year program offers training in clinical trial design, protocol development, patient care, toxicity management and more. Applications are due Aug. 18. https://sitcancer.org/nci-immunotherapy-fellowship #Fellowship #IO #SITC

New #JITC article: "Lenalidomide boosts CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2-T cell effector functions via CD28, Notch signaling and IL-2 release" jitc.bmj.com/content/14/6... 🧪

New review: "Emerging role of microRNAs as modulators of the tumor immune microenvironment" jitc.bmj.com/content/14/6...

One week until webinar 3 of the 2026 SITC Computational IO Series. Learn how immune-based approaches are shaping the future of early cancer detection. Learn more and register today! https://www.sitcancer.org/edu/webinars/computational

What’s powering the next generation of IO? Join the Panel Discussion: Next Wave IO Platforms at the 2026 SITC EU Immuno-Oncology Drug Development Summit & hear how emerging platforms are reshaping drug discovery and development. sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

New #JITC article: "Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma" jitc.bmj.com/content/14/6...

New #JITC article: "IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy" jitc.bmj.com/content/14/6... 🧪

The immune composition of a tumor has a major impact on IO response. Join leading experts Nov. 7 at #SITC26 as they examine strategies to modify tumor composition. Browse the session agenda: https://ow.ly/vtKH50Zjhf8 BrownLab @Mt.Sinai Jennifer Guerriero, PhD OncoDaily

Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar#SITC#Immunotherapy

Dr. Shimon Sakaguchi, 2025 Nobel Prize Recipient in Physiology or Medicine, is presenting a special lecture on Tregs at JACI 2026. Organized in collaboration with SITC, this meeting is held July 22–24, in Kagawa, Japan or virtual. View more: https://ow.ly/JStU50Z2eZx OncoDaily

What’s next for IO innovation? Hear from industry leaders during this investment-focused discussion at the EU IO Drug Development Summit on Sept. 3 in Lausanne, Switzerland. Register: https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

Important info from @sitcancer.bsky.social - we have so much to learn. Please comment on how this might change practice #cansky #medsky We need better answers than steroids!

Now is the time to reconnect with the SITC community! Renew your SITC membership to continue collaborating and networking with peers, leaders and mentees in the #IO field. https://www.sitcancer.org/renew

Please help grow response and re-post to reach as many cancer immunotherapy patients as possible.

Take advantage of early rates and register for #SITC26. Our 41st Annual Meeting and Pre-Conference Programs will be held in Phoenix, AZ on Nov. 4–8. Early registration ends Aug. 24. Learn more here: https://www.sitcancer.org/2026/home#SITC26

It’s Forward Fund Friday. Behind every life‑changing therapy is a scientist who once needed early‑career investment and mentorship — many FAIO members began the same way. To keep the field advancing, support those just starting out. Donate: givebutter.com/sitc-forward... #CancerImmunotherapyMonth

Join leading experts to learn about the role of regulatory T cells (Tregs) at the EU IO Drug Development Summit. Gain valuable insights, hear the latest perspectives from across the field, and connect with the ideas shaping the future of IO. Secure your spot today! sitcancer.org/eu-io-summit

SITC leaders Dr. James L. Gulley & Dr. Zhen Su ring the NYSE Opening Bell, symbolizing progress in immune-oncology and commemorating the annual SITC Biotech Strategic Meeting at the NYSE. www.sitcancer.org/about/strate... @oncodaily.bsky.social #SITCQuestfor100 @endpts.com

It’s Forward Fund Friday. Careers in immuno‑oncology are built through guidance, opportunity, and early support. Even today’s leaders, including FAIO members, grew because someone invested in their potential. Lift up the next generation. Donate: givebutter.com/sitc-forward... @oncodaily.bsky.social

New #JITC article: "Integrin CD11b/CD18 reprograms macrophage polarization by suppressing ERK/STAT3 signaling to enhance antitumor immunity in colitis-associated colorectal cancer" jitc.bmj.com/content/14/6... 🧪

Discover the latest advances in lung cancer IO and earn free CME! Join clinical experts during SITC's ACI: A Focus on Lung Cancer program Aug. 26 to access the most recent updates in the field. Learn more: https://www.sitcancer.org/edu/aci/lung-cancer @fionnualacrowley.bsky.social

New #JITC article: "Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases" jitc.bmj.com/content/14/6... #cancer #research

Abstract submission deadline for #SITC26 is today at 5 p.m. PT for Regular and Early Career Investigator Award Abstracts! 41 abstract travel awards will be awarded. Submit your cutting-edge research today: sitcancer.org/2026/abstracts/abstract-submission

June is Cancer Immunotherapy Month - at #SITC25 Dr. Cathy Wu presented a novel approach to discover and characterize shared antigens and neoantigens from the dark genome and its potential impact on cancer vaccine development. Watch it w/ SITC OnDemand: ondemand.sitcancer.org/media/26c1da...

How can engineered immune cell therapies overcome the unique challenges of solid tumors? Join Denis Migliorini, MD, at the EU IO Drug Development Summit for a dive into the latest advances, emerging strategies, & future directions shaping IO. sitcancer.org/edu-sitc-biotech-initiative/eu-io-summit

Regular & Early Career Investigator Award Abstract submissions for #SITC26 close tomorrow. All accepted abstracts will have the opportunity to present in the poster hall and are published in the Journal for ImmunoTherapy of Cancer (JITC). https://www.sitcancer.org/2026/abstracts/abstract-submission

New #JITC article: "Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy" jitc.bmj.com/content/14/6... 🧪

Immune cell engagers are transforming cancer treatment. Join Anna Farago, MD, PhD, to learn how these therapies are advancing and what they could mean for patients and drug developers. Sept. 3–4 in Lausanne, Switzerland. https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

Fun development: This panel participation @sitcancer.bsky.social led to an invited review paper on mapping the computational landscape for TCR analysis, which is now online at #JITC. Big thanks to my trainee Pamela Borges, who led the effort, and all the co-authors. jitc.bmj.com/content/14/6...

#CIM – On Forward Fund Friday, we recognize the opportunities provided through your donations. Providing Early Career Scientists the funding to develop research through fellowships is helping to shape the future in IO. Contribute & make an impact today. givebutter.com/sitc-forward...

Host–microbe interactions are opening new doors in cancer IO! Join experts Nov. 7 at #SITC26 to examine the microbiome's growing role in cancer development, tumor immunity and response to therapy. Learn more: https://ow.ly/eBvC50ZcLuc Maayan Levy, PhD Golnaz Morad#SITC26 #CIM

#CIM – It’s Forward Fund Friday. The Steven A. Rosenberg Scholars Award honors Dr. Rosenberg and his critical contributions to IO. Financially supporting this award and other SITC fellowships, helps launch ECS careers. Make a difference, donate today: ow.ly/gfA750ZemCR

Learn how immune-based approaches are shaping the future of early cancer detection in Webinar 3 of the 2026 SITC Computational IO Series on July 9. Don’t miss insights from leaders in computational IO: https://www.sitcancer.org/edu/webinars/computational

How are the next generation of IO biotech companies being built? Join this opening panel at the NYSE program to hear CEOs and industry leaders discuss funding, innovation, partnerships & growth strategies shaping the future of IO. Registration ends Sunday! Sitcancer.org/2026-sitc-biotech-nyse

Join leading experts as they explore emerging modalities Beyond PD-1, discussing vaccines, multi-/bi-specific antibodies, & the future of IO drug development. Gain insights from industry leaders & innovators shaping the next generation of cancer IO. sitcancer.org/eu-io-summit

Use our Connect-a-Colleague Tool to refer your colleagues to join #SITC! The top referrer will be recognized at #SITC26. sitcancer.org/connect-a-colleague

Are you devoted to #makingcurereality? Renew your SITC membership today to continue collaborating with a global network of professionals dedicated to helping improve cancer patient outcomes. https://www.sitcancer.org/renew

Address critical challenges with JITC Editor-in-Chief Dr. Michael Lotze's selection of recent editorials and hypotheses! The June Issue of the #JITC Digest features commentaries on recent research, helping readers better understand their significance. Read Digest: www.sitcancer.org/blogs/jitc-p...

Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: https://www.sitcancer.org/2026/home#SITC26

Explore innovative approaches targeting PRAME+ cancers with Cedrik M. Britten, MD. Learn about the clinical development of TCR T-cell therapies and bispecific T-cell engagers. Learn more and register: https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

Don’t miss the first webinar in our Deep Dive Series, happening June 30th! Explore the mechanisms and clinical development of PD-1/VEGF bispecifics with expert faculty examining emerging biology, engineering strategies, and the latest clinical data. sitcancer.org/edu/webinars/targets-for-cancer-io

New #JITC review: "Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy" jitc.bmj.com/content/14/6... #cancer #IO 🧪

Please take the survey and re-post to help grow response! Thanks. @oncodaily.bsky.social

Expert SITC speaker Lili Yang, PhD, UCLA is sharing insights on serotonin transporter inhibition at JACI 2026. Explore the latest updates on intratumoral therapies July 22–24, in Kagawa, Japan or virtual. Learn more: https://ow.ly/Ml0i50Z2ek4 OncoDaily

Opportunities and challenges with myeloid cells in cancer biology! Access in-depth reviews and questions with a new #JITC special series, "Myeloid Cells in Immuno-Oncology", edited by Drs. Dmitry I. Gabrilovich, Jennifer L. Guerriero, and Judith A. Varner. View full series: https://ow.ly/VWMz50ZbbuI

#CIM – On SITC's Forward Fund Friday, we recognize the opportunities provided via your donations. Providing Early Career Scientists, the funding to share their research through travel awards is catapulting careers in #IO. Contribute and make an impact today. givebutter.com/sitc-forward... #GiveBack

Join us for the Targets for Cancer IO: A Deep Dive Series—an expert-led webinar program exploring cutting-edge science and therapeutic innovation in immuno-oncology. Learn more about these webinars and register here: https://www.sitcancer.org/edu/webinars/targets-for-cancer-io

#CIM – It’s Forward Fund (FF) Friday. Your donation to the FF provides ECS opportunities to share their research w/ IO leaders through SITC travel awards & Early Career Investigator Awards. Your support is launching careers in IO to benefit Cx patients. givebutter.com/sitc-forward...